With no word yet on who will lead the Federal Trade Commission under the next administration, private equity investors say there’s a lot of uncertainty about the healthcare dealmaking landscape for 2025.
Under current chair Lina Khan, the FTC has scrutinized closely PE-backed healthcare deals and their impact on the quality and affordability of patient care, pursuing extensive investigations into hospital investments as well as rollup strategies that PE firms employ to consolidate smaller businesses and providers.
